Ptc Therapeutics, Inc. · NASDAQ:PTCT

Klein Matthew B. sold 10,292 Ptc Therapeutics, Inc. shares (Form 4)

Traded Aug 4, 2026 · Filed Aug 6, 2026

On Aug 4, 2026, Klein Matthew B. (Director, CHIEF EXECUTIVE OFFICER) sold 10,292 Ptc Therapeutics, Inc. shares at US$68.57 for US$706K under a trading plan, leaving 383,868 shares. Filed Aug 6, 2026 (Form 4).

Sold
10,292 shares
Price
US$68.57
Value
US$706K
Holding after
383,868 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CHIEF EXECUTIVE OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 4, 2026Common StockSale10,292US$68.57383,868Direct

Source

View original at SEC

Related